Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.
- Published In:
- British journal of hospital medicine (London, England : 2005), 86(9), 1-14 (2025)
- Authors:
- Wu, Guofeng, Sun, Xuelian
- Database ID:
- RPEP-14189
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14189APA
Wu, Guofeng; Sun, Xuelian. (2025). Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.. British journal of hospital medicine (London, England : 2005), 86(9), 1-14. https://doi.org/10.12968/hmed.2025.0235
MLA
Wu, Guofeng, et al. "Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential Treatment of Pulmonary Tuberculosis: An Analysis of Immune Function, Pulmonary Function and Inflammatory Response.." British journal of hospital medicine (London, 2025. https://doi.org/10.12968/hmed.2025.0235
RethinkPeptides
RethinkPeptides Research Database. "Thymosin α1 Combined With 2HRZE/4HR Regimen as a Potential T..." RPEP-14189. Retrieved from https://rethinkpeptides.com/research/wu-2025-thymosin-1-combined-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.